Nome
1 known investors
Find your way into Nome
Nome offers genetic medicine development as a service, helping rare disease families, foundations, and health systems access and develop personalized n-of-1 genetic therapies. It combines an AI platform with human experts to guide therapeutic programs from treatment design through clinical execution.
Founders & leadership
SR
Stevie RingelFounder
Investors · 1
Frequently asked questions
- What does Nome do?
- Nome offers genetic medicine development as a service, helping rare disease families, foundations, and health systems access and develop personalized n-of-1 genetic therapies. It combines an AI platform with human experts to guide therapeutic programs from treatment design through clinical execution.
- Who founded Nome?
- Nome was founded by Stevie Ringel.
- Who are Nome's investors?
- Nome's investors include Twelve Below.